10x Genomics vs Figma

Side-by-side comparison of AI visibility scores, market position, and capabilities

Figma leads in AI visibility (99 vs 23)
10x Genomics logo

10x Genomics

EstablishedLife Sciences & BioTech

Genomics & Single-Cell Analysis

Leading single-cell genomics platform; $642M FY2025 revenue. Chromium and Visium spatial platforms power cell-type discovery in oncology, neuroscience, and immunology.

AI VisibilityBeta
Overall Score
D23
Category Rank
#1 of 1
AI Consensus
59%
Trend
up
Per Platform
ChatGPT
25
Perplexity
27
Gemini
34

About

10x Genomics was founded in 2012 in Pleasanton, California by Serge Saxonov, Ben Hindson, and Kevin Ness. The company developed the Chromium platform for single-cell RNA sequencing (scRNA-seq), enabling researchers to analyze gene expression across thousands of individual cells simultaneously—a capability that transformed cell biology, immunology, and cancer research. The Visium Spatial Gene Expression platform extended this to map gene expression within intact tissue architecture.\n\n10x Genomics' instruments and consumables are used by leading academic research centers, pharmaceutical companies, and translational medicine teams to profile the cellular composition of tumors, map the nervous system, characterize immune responses, and develop cell therapies. The company reported full-year 2025 revenue of $642.8 million, up from $610.8 million in 2024, and guides to $600–$625 million for 2026 amid cautious biotech funding conditions.\n\nThe company is transitioning toward a broader multi-omics portfolio including ATAC-seq, protein detection, and spatial multi-omics, while defending market position against competition from Parse Biosciences, Vizgen, and others. Despite near-term funding headwinds in academic markets, 10x Genomics remains a foundational infrastructure provider for the cell atlas era of biology.

Full profile
Figma logo

Figma

LeaderDesign & Creative Tools

Design & Collaboration

Dominant browser-based collaborative UI design platform at ~$600M ARR and $12.5B valuation; Adobe's $20B acquisition blocked by regulators in 2023, Figma remains independent competing with Sketch and Adobe.

AI VisibilityBeta
Overall Score
A99
Category Rank
#1 of 1
AI Consensus
77%
Trend
stable
Per Platform
ChatGPT
90
Perplexity
99
Gemini
97

About

Figma is a San Francisco-based collaborative web-based product design platform that has become the dominant tool for UI/UX designers and product teams — enabling real-time multi-user collaboration on interface design, prototyping, and design system management directly in the browser without installing desktop software. Founded in 2012 by Dylan Field and Evan Wallace and backed by Sequoia, Greylock, and Andreessen Horowitz with over $330 million raised, Figma generated approximately $600 million in ARR in 2023, serving 4 million+ designers and product teams at companies including Microsoft, Airbnb, Twitter, and Uber. Adobe announced a $20 billion acquisition offer in 2022, which was blocked by regulators in 2023 — Figma remains independent.

Full profile

AI Visibility Head-to-Head

23
Overall Score
99
#1
Category Rank
#1
59
AI Consensus
77
up
Trend
stable
25
ChatGPT
90
27
Perplexity
99
34
Gemini
97
25
Claude
94
15
Grok
99

Capabilities & Ecosystem

Capabilities

Only 10x Genomics
Genomics & Single-Cell Analysis
Only Figma
Design & Collaboration

Integrations

Figma is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.